Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1600p (from 1800p).